These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1051 related items for PubMed ID: 17460297
21. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Nagai N, Oike Y, Izumi-Nagai K, Urano T, Kubota Y, Noda K, Ozawa Y, Inoue M, Tsubota K, Suda T, Ishida S. Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2252-9. PubMed ID: 16888236 [Abstract] [Full Text] [Related]
22. [Expression of vascular endothelial growth factor and its receptor in experimental choroidal neovascularization in rat]. Zhao SH, He SZ, Shi XH. Zhonghua Yan Ke Za Zhi; 2004 Aug; 40(8):522-7. PubMed ID: 15454039 [Abstract] [Full Text] [Related]
23. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2. Mochimaru H, Nagai N, Hasegawa G, Kudo-Saito C, Yaguchi T, Usui Y, Kurihara T, Koto T, Satofuka S, Shinoda H, Ozawa Y, Tsubota K, Kawakami Y, Ishida S. Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4795-801. PubMed ID: 17898306 [Abstract] [Full Text] [Related]
24. Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury. Chen R, Iwai M, Wu L, Suzuki J, Min LJ, Shiuchi T, Sugaya T, Liu HW, Cui TX, Horiuchi M. Hypertension; 2003 Oct; 42(4):542-7. PubMed ID: 12963679 [Abstract] [Full Text] [Related]
25. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, Bennett J, Tolentino MJ. Mol Vis; 2003 May 30; 9():210-6. PubMed ID: 12789138 [Abstract] [Full Text] [Related]
26. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system. Hara C, Kasai A, Gomi F, Satooka T, Sakimoto S, Nakai K, Yoshioka Y, Yamamuro A, Maeda S, Nishida K. Invest Ophthalmol Vis Sci; 2013 Jun 21; 54(6):4321-9. PubMed ID: 23722395 [Abstract] [Full Text] [Related]
27. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors. Linz W, Schölkens BA. J Cardiovasc Pharmacol; 1992 Jun 21; 20 Suppl 9():S83-90. PubMed ID: 1282635 [Abstract] [Full Text] [Related]
28. VEGF is major stimulator in model of choroidal neovascularization. Kwak N, Okamoto N, Wood JM, Campochiaro PA. Invest Ophthalmol Vis Sci; 2000 Sep 21; 41(10):3158-64. PubMed ID: 10967078 [Abstract] [Full Text] [Related]
29. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin. Tomida D, Nishiguchi KM, Kataoka K, Yasuma TR, Iwata E, Uetani R, Kachi S, Terasaki H. Invest Ophthalmol Vis Sci; 2011 May 16; 52(6):3193-9. PubMed ID: 21296829 [Abstract] [Full Text] [Related]
30. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization. Zambarakji HJ, Nakazawa T, Connolly E, Lane AM, Mallemadugula S, Kaplan M, Michaud N, Hafezi-Moghadam A, Gragoudas ES, Miller JW. Invest Ophthalmol Vis Sci; 2006 Jun 16; 47(6):2623-31. PubMed ID: 16723479 [Abstract] [Full Text] [Related]
31. Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization. Zhao SH, Pan DY, Zhang Y, Wu JH, Liu X, Xu Y. Chin Med J (Engl); 2010 Mar 20; 123(6):713-21. PubMed ID: 20368092 [Abstract] [Full Text] [Related]
32. Dendritic cells augment choroidal neovascularization. Nakai K, Fainaru O, Bazinet L, Pakneshan P, Benny O, Pravda E, Folkman J, D'Amato RJ. Invest Ophthalmol Vis Sci; 2008 Aug 20; 49(8):3666-70. PubMed ID: 18408184 [Abstract] [Full Text] [Related]
34. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor. Fukuda K, Hirooka K, Mizote M, Nakamura T, Itano T, Shiraga F. Invest Ophthalmol Vis Sci; 2010 Jul 21; 51(7):3629-38. PubMed ID: 20164447 [Abstract] [Full Text] [Related]
35. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T. Int Immunopharmacol; 2003 Mar 21; 3(3):335-44. PubMed ID: 12639811 [Abstract] [Full Text] [Related]
36. Octreotide inhibits choroidal neovascularization in rats. Qu Y, Zhang S, Xu X, Wang H, Li J, Zhou F, Wei F. Ophthalmic Res; 2009 Mar 21; 42(1):36-42. PubMed ID: 19478539 [Abstract] [Full Text] [Related]
37. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Pharmacol Rev; 1995 Mar 21; 47(1):25-49. PubMed ID: 7784479 [Abstract] [Full Text] [Related]
38. Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization. Yoshikawa N, Noda K, Ozawa Y, Tsubota K, Mashima Y, Ishida S. Mol Vis; 2012 Mar 21; 18():593-600. PubMed ID: 22419852 [Abstract] [Full Text] [Related]
39. (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system. Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, Tsubota K, Itoh H, Oike Y, Ishida S. Am J Pathol; 2008 Dec 21; 173(6):1911-8. PubMed ID: 18974301 [Abstract] [Full Text] [Related]
40. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Umezawa K, Ohno S, Oike Y, Ishida S. Arterioscler Thromb Vasc Biol; 2007 Dec 21; 27(12):2555-62. PubMed ID: 17932319 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]